A Meta-analysis of Thyroid-related Traits Reveals Novel Loci and Gender-specific Differences in the Regulation of Thyroid Function

Thyroid hormone is essential for normal metabolism and development, and overt abnormalities in thyroid function lead to common endocrine disorders affecting approximately 10% of individuals over their life span. In addition, even mild alterations in thyroid function are associated with weight changes, atrial fibrillation, osteoporosis, and psychiatric disorders. To identify novel variants underlying thyroid function, we performed a large meta-analysis of genome-wide association studies for serum levels of the highly heritable thyroid function markers TSH and FT4, in up to 26,420 and 17,520 euthyroid subjects, respectively. Here we report 26 independent associations, including several novel loci for TSH (PDE10A, VEGFA, IGFBP5, NFIA, SOX9, PRDM11, FGF7, INSR, ABO, MIR1179, NRG1, MBIP, ITPK1, SASH1, GLIS3) and FT4 (LHX3, FOXE1, AADAT, NETO1/FBXO15, LPCAT2/CAPNS2). Notably, only limited overlap was detected between TSH and FT4 associated signals, in spite of the feedback regulation of their circulating levels by the hypothalamic-pituitary-thyroid axis. Five of the reported loci (PDE8B, PDE10A, MAF/LOC440389, NETO1/FBXO15, and LPCAT2/CAPNS2) show strong gender-specific differences, which offer clues for the known sexual dimorphism in thyroid function and related pathologies. Importantly, the TSH-associated loci contribute not only to variation within the normal range, but also to TSH values outside the reference range, suggesting that they may be involved in thyroid dysfunction. Overall, our findings explain, respectively, 5.64% and 2.30% of total TSH and FT4 trait variance, and they improve the current knowledge of the regulation of hypothalamic-pituitary-thyroid axis function and the consequences of genetic variation for hypo- or hyperthyroidism.

Citing Articles

The causal relationship between thyroid dysfunction and carpal tunnel syndrome: A Mendelian randomization study.

Zhang F, Cui R, Yin L, Bi R, Xu H, Wang S Medicine (Baltimore). 2025; 104(9):e41648.

PMID: 40020106 PMC: 11875579. DOI: 10.1097/MD.0000000000041648.

Clearing the Skepticism about Subclinical Hypothyroidism: Is It Beneficial to Treat Patients with Thyroid-Stimulating Hormone >4.5 and <10 mIU/L?.

Bushra H, Rashid M Avicenna J Med. 2024; 14(3):137-145.

PMID: 39584162 PMC: 11581835. DOI: 10.1055/s-0044-1788040.

Genome-wide association studies of thyroid-related hormones, dysfunction, and autoimmunity among 85,421 Chinese pregnancies.

Wei Y, Zhen J, Hu L, Gu Y, Liu Y, Guo X Nat Commun. 2024; 15(1):8004.

PMID: 39266554 PMC: 11393459. DOI: 10.1038/s41467-024-52236-2.

Novel insights into the pleiotropic health effects of growth differentiation factor 11 gained from genome-wide association studies in population biobanks.

Strosahl J, Ye K, Pazdro R BMC Genomics. 2024; 25(1):837.

PMID: 39237910 PMC: 11378601. DOI: 10.1186/s12864-024-10710-7.

Three candidate SNPs show associations with thyroid-stimulating hormone in euthyroid subjects: Tehran thyroid study.

Zadeh-Vakili A, Najd-Hassan-Bonab L, Akbarzadeh M, Abdi H, Zahedi A, Azizi F J Diabetes Metab Disord. 2024; 23(1):1047-1055.

PMID: 38932823 PMC: 11196493. DOI: 10.1007/s40200-023-01383-2.

References

Landa I, Ruiz-Llorente S, Montero-Conde C, Inglada-Perez L, Schiavi F, Leskela S . The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors. PLoS Genet. 2009; 5(9):e1000637. PMC: 2727793. DOI: 10.1371/journal.pgen.1000637. View

Arnaud-Lopez L, Usala G, Ceresini G, Mitchell B, Pilia M, Piras M . Phosphodiesterase 8B gene variants are associated with serum TSH levels and thyroid function. Am J Hum Genet. 2008; 82(6):1270-80. PMC: 2427267. DOI: 10.1016/j.ajhg.2008.04.019. View

De Felice M, Ovitt C, Biffali E, Arra C, Anastassiadis K, Macchia P . A mouse model for hereditary thyroid dysgenesis and cleft palate. Nat Genet. 1998; 19(4):395-8. DOI: 10.1038/1289. View

Jendrzejewski J, He H, Radomska H, Li W, Tomsic J, Liyanarachchi S . The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type. Proc Natl Acad Sci U S A. 2012; 109(22):8646-51. PMC: 3365219. DOI: 10.1073/pnas.1205654109. View

Shields B, Freathy R, Knight B, Hill A, Weedon M, Frayling T . Phosphodiesterase 8B gene polymorphism is associated with subclinical hypothyroidism in pregnancy. J Clin Endocrinol Metab. 2009; 94(11):4608-12. DOI: 10.1210/jc.2009-1298. View

de Jong F, Peeters R, den Heijer T, Van der Deure W, Hofman A, Uitterlinden A . The association of polymorphisms in the type 1 and 2 deiodinase genes with circulating thyroid hormone parameters and atrophy of the medial temporal lobe. J Clin Endocrinol Metab. 2006; 92(2):636-40. DOI: 10.1210/jc.2006-1331. View

Toft A . Clinical practice. Subclinical hyperthyroidism. N Engl J Med. 2001; 345(7):512-6. DOI: 10.1056/NEJMcp010145. View

Zhou R, Bonneaud N, Yuan C, de Santa Barbara P, Boizet B, Schomber T . SOX9 interacts with a component of the human thyroid hormone receptor-associated protein complex. Nucleic Acids Res. 2002; 30(14):3245-52. PMC: 135763. DOI: 10.1093/nar/gkf443. View

Teumer A, Rawal R, Homuth G, Ernst F, Heier M, Evert M . Genome-wide association study identifies four genetic loci associated with thyroid volume and goiter risk. Am J Hum Genet. 2011; 88(5):664-73. PMC: 3146733. DOI: 10.1016/j.ajhg.2011.04.015. View

10.

Andersen S, Pedersen K, Bruun N, Laurberg P . Narrow individual variations in serum T(4) and T(3) in normal subjects: a clue to the understanding of subclinical thyroid disease. J Clin Endocrinol Metab. 2002; 87(3):1068-72. DOI: 10.1210/jcem.87.3.8165. View

11.

Takahashi M, Saenko V, Rogounovitch T, Kawaguchi T, Drozd V, Takigawa-Imamura H . The FOXE1 locus is a major genetic determinant for radiation-related thyroid carcinoma in Chernobyl. Hum Mol Genet. 2010; 19(12):2516-23. DOI: 10.1093/hmg/ddq123. View

12.

Braunschweig T, Kaserer K, Chung J, Bilke S, Krizman D, Knezevic V . Proteomic expression profiling of thyroid neoplasms. Proteomics Clin Appl. 2010; 1(3):264-71. DOI: 10.1002/prca.200600381. View

13.

Rawal R, Teumer A, Volzke H, Wallaschofski H, Ittermann T, Asvold B . Meta-analysis of two genome-wide association studies identifies four genetic loci associated with thyroid function. Hum Mol Genet. 2012; 21(14):3275-82. DOI: 10.1093/hmg/dds136. View

14.

Medici M, Van der Deure W, Verbiest M, Vermeulen S, Hansen P, Kiemeney L . A large-scale association analysis of 68 thyroid hormone pathway genes with serum TSH and FT4 levels. Eur J Endocrinol. 2011; 164(5):781-8. DOI: 10.1530/EJE-10-1130. View

15.

Taylor P, Panicker V, Sayers A, Shields B, Iqbal A, Bremner A . A meta-analysis of the associations between common variation in the PDE8B gene and thyroid hormone parameters, including assessment of longitudinal stability of associations over time and effect of thyroid hormone replacement. Eur J Endocrinol. 2011; 164(5):773-80. PMC: 3080745. DOI: 10.1530/EJE-10-0938. View

16.

Panicker V, Cluett C, Shields B, Murray A, Parnell K, Perry J . A common variation in deiodinase 1 gene DIO1 is associated with the relative levels of free thyroxine and triiodothyronine. J Clin Endocrinol Metab. 2008; 93(8):3075-81. PMC: 2515080. DOI: 10.1210/jc.2008-0397. View

17.

Duan C, Clemmons D . Transcription factor AP-2 regulates human insulin-like growth factor binding protein-5 gene expression. J Biol Chem. 1995; 270(42):24844-51. DOI: 10.1074/jbc.270.42.24844. View

18.

Senee V, Chelala C, Duchatelet S, Feng D, Blanc H, Cossec J . Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism. Nat Genet. 2006; 38(6):682-7. DOI: 10.1038/ng1802. View

19.

Helmreich D, Parfitt D, Lu X, Akil H, Watson S . Relation between the hypothalamic-pituitary-thyroid (HPT) axis and the hypothalamic-pituitary-adrenal (HPA) axis during repeated stress. Neuroendocrinology. 2005; 81(3):183-92. DOI: 10.1159/000087001. View

20.

Vamos E, Pardutz A, Klivenyi P, Toldi J, Vecsei L . The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection. J Neurol Sci. 2009; 283(1-2):21-7. DOI: 10.1016/j.jns.2009.02.326. View